# Realize the Current Situation of COPD Patients in China

> **NCT03131362** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5020 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease COPD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03131362
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-30
- **Primary completion:** 2020-08-06
- **Final completion:** 2020-08-06
- **Target enrollment:** 5020 (ACTUAL)
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03131362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03131362, "Realize the Current Situation of COPD Patients in China". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03131362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*